Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Oblong, Inc. | Director | Common Warrant | 61.4K | $190K | $3.09 | Sep 17, 2025 | Direct |
TAO Synergies Inc. | Director | Common Stock, par value $0.0001 per share | 14K | $110K | $7.85 | Jun 30, 2025 | Direct |
Oblong, Inc. | Director | COMMON STOCK | 15K | $40.4K | $2.70 | Sep 17, 2025 | Direct |
PharmaCyte Biotech, Inc. | Director | Stock Option (Right to Buy) | 38K | Apr 30, 2024 | Direct | ||
Synaptogenix, Inc. | Director | Stock Option (Right to Buy) | 800 | Apr 3, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OBLG | Oblong, Inc. | Sep 17, 2025 | 1 | $13.5K | 4 | Sep 17, 2025 | Director |
OBLG | Oblong, Inc. | Sep 16, 2025 | 1 | $27.3K | 4 | Sep 16, 2025 | Director |
TAOX | TAO Synergies Inc. | Jun 30, 2025 | 2 | -$67.7K | 4 | Jul 2, 2025 | Director |
SNPX | Synaptogenix, Inc. | Apr 3, 2025 | 1 | $0 | 4 | Apr 7, 2025 | Director |
PMCB | PharmaCyte Biotech, Inc. | Apr 30, 2024 | 1 | $0 | 4 | Jul 17, 2024 | Director |
SNPX | Synaptogenix, Inc. | Apr 8, 2024 | 1 | $0 | 4 | Apr 10, 2024 | Director |
PMCB | PharmaCyte Biotech, Inc. | Nov 20, 2023 | 1 | $0 | 4 | Nov 22, 2023 | Director |
OBLG | Oblong, Inc. | May 29, 2023 | 0 | $0 | 3 | Jun 1, 2023 | Director |
SNPX | Synaptogenix, Inc. | Mar 29, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Director |
SNPX | Synaptogenix, Inc. | Dec 16, 2022 | 1 | -$23.7K | 4 | Dec 20, 2022 | Director |
SNPX | Synaptogenix, Inc. | Nov 15, 2022 | 1 | $0 | 4 | Nov 17, 2022 | Director |
PMCB | PharmaCyte Biotech, Inc. | Aug 15, 2022 | 0 | $0 | 3 | Aug 23, 2022 | Director |
SNPX | Synaptogenix, Inc. | Apr 5, 2022 | 1 | $0 | 4/A | Jun 23, 2022 | Director |
SNPX | Synaptogenix, Inc. | Jul 13, 2021 | 1 | $0 | 4 | Jul 15, 2021 | Director |
SNPX | Synaptogenix, Inc. | Jun 4, 2021 | 0 | $0 | 3/A | Jun 17, 2021 | Director |